Effects of cancer, radiotherapy and cytotoxic drugs on intestinal structure and function.
D000477:Alkylating Agents / Q000009:adverse effects; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D007421:Intestine, Small / Q000473:pathology / Q000503:physiopathology; D008286:Malabsorption Syndromes / Q000209:etiology*; D009369:Neoplasms / Q000150:complications* / Q000628:therapy; D011832:Radiation Injuries; D014748:Vinca Alkaloids / Q000009:adverse effects
D000477:Alkylating Agents; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D014748:Vinca Alkaloids; D004317:Doxorubicin